Detalles de la búsqueda
1.
Characterisation of the Phosphatidylinositol 3-Kinase Pathway in Non-Small Cell Lung Cancer Cells Isolated from Pleural Effusions.
Oncology
; 90(5): 280-8, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27082424
2.
A serum mesothelin level is a prognostic indicator for patients with malignant mesothelioma in routine clinical practice.
BMC Cancer
; 14: 674, 2014 Sep 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-25227779
3.
Olaparib as maintenance treatment in patients with chemosensitive small cell lung cancer (STOMP): A randomised, double-blind, placebo-controlled phase II trial.
Lung Cancer
; 171: 26-33, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35872530
4.
Rationale and Design of the Phase III KEYLYNK-012 Study of Pembrolizumab and Concurrent Chemoradiotherapy Followed by Pembrolizumab With or Without Olaparib for Stage III Non-Small-Cell Lung Cancer.
Clin Lung Cancer
; 23(6): e342-e346, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35618629
5.
Up-front cell-free DNA next generation sequencing improves target identification in UK first line advanced non-small cell lung cancer (NSCLC) patients.
Eur J Cancer
; 171: 44-54, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35704974
6.
Safety monitoring of two and four-weekly adjuvant durvalumab for patients with stage III NSCLC: implications for the COVID-19 pandemic and beyond.
Lung Cancer
; 156: 147-150, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33965281
7.
HER3 expression and MEK activation in non-small-cell lung carcinoma.
Lung Cancer Manag
; 10(2): LMT48, 2021 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34084213
8.
Immune Checkpoint Inhibitor and Radiotherapy-Related Pneumonitis: An Informatics Approach to Determine Real-World Incidence, Severity, Management, and Resource Implications.
Front Med (Lausanne)
; 8: 764563, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34790682
9.
Real-world outcomes in thoracic cancer patients with severe Acute respiratory syndrome Coronavirus 2 (COVID-19): Single UK institution experience.
Cancer Treat Res Commun
; 25: 100261, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33310368
10.
Systemic treatment of brain metastases in non-small cell lung cancer.
Eur J Cancer
; 132: 187-198, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32380429
11.
Defining the true impact of coronavirus disease 2019 in the at-risk population of patients with cancer.
Eur J Cancer
; 136: 99-106, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32659475
12.
A prospective observational study of on-treatment plasma homocysteine levels as a biomarker of toxicity, depression and vitamin supplementation lead-in time pre pemetrexed, in patients with non-small cell lung cancer and malignant mesothelioma.
PLoS One
; 14(11): e0225509, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31765437
13.
Clinical Activity, Tolerability, and Long-Term Follow-Up of Durvalumab in Patients With Advanced NSCLC.
J Thorac Oncol
; 14(10): 1794-1806, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31228626
14.
Molecular Adequacy of Image-Guided Rebiopsies for Molecular Retesting in Advanced Non-Small Cell Lung Cancer: A Single-Center Experience.
J Thorac Oncol
; 13(1): 63-72, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28989040
15.
A phase I study to assess afatinib in combination with carboplatin or with carboplatin plus paclitaxel in patients with advanced solid tumors.
Cancer Chemother Pharmacol
; 82(5): 757-766, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30088048
16.
A study of PD-L1 expression in KRAS mutant non-small cell lung cancer cell lines exposed to relevant targeted treatments.
PLoS One
; 12(10): e0186106, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28982179
17.
Phase I clinical trials in patients with advanced non-small cell lung cancer treated within a Drug Development Unit: What have we learnt?
Lung Cancer
; 111: 6-11, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28838399
18.
Clinical outcomes and prognostic factors of patients with advanced mesothelioma treated in a phase I clinical trials unit.
Eur J Cancer
; 75: 56-62, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28214659
19.
Development of molecularly targeted agents and immunotherapies in small cell lung cancer.
Eur J Cancer
; 60: 26-39, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27060747
20.
A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients.
Cancer Chemother Pharmacol
; 77(2): 375-83, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26706729